All News
Filter News
Found 808,606 articles
-
Ridge Diagnostics, Inc. and Ameritox, Ltd. Enter Into Licensing Agreement for Depression Biomarker Blood Test
4/5/2012
-
Cascade Technologies Signs Definitive Agreement for $4 Million Financing to Support Its Lead Product Candidates
4/5/2012
-
Life Technologies to Accelerate Adoption of Next-Generation Sequencing in HLA Through Key Partnerships
4/5/2012
-
GenMark Diagnostics and Advanced Liquid Logic Enter into Agreement to Develop an All-Electronic Fully Integrated Diagnostic Platform
4/5/2012
-
AB SCIEX and Phenomenex, Inc. Develop Food Safety Solution for India
4/5/2012
-
Purdue Pharma L.P. Release: Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV Are Now Available for Insomnia Characterized by Middle-of-the-Night Awakenings Followed by Difficulty Returning to Sleep
4/5/2012
-
Transcept Pharmaceuticals, Inc. Announces National Product Launch of Intermezzo(R) by Purdue Pharma L.P.
4/5/2012
-
Immune Response BioPharma Announce Formulation Changes for REMUNE to Weekly & Monthly Dosing
4/5/2012
-
Avita Medical Granted European Patent Covering Platform Technology
4/5/2012
-
Biotage AB Publishes its 2011 Annual Report and Corporate Governance Report
4/5/2012
-
Summit Corporation Release: Director and PDMR Share Dealings
4/5/2012
-
Aptalis Pharmaceutical Technologies Commences Tender Offer for Its 12 3/4% Senior Notes Due 2016 and Solicitation of Consents
4/5/2012
-
Galena Biopharma Announces Pricing of Public Offering of Common Stock
4/5/2012
-
NeoStem, Inc. Closes Public Offering for $6,800,000 in Gross Proceeds
4/5/2012
-
Pressure BioSciences, Inc. Common Stock to Begin Trading Today on the OTCQB(TM) Tier of the OTC Marketplace
4/5/2012
-
University of Massachusetts Medical School Release: 5th Academic and Health Policy Conference on Correctional Health Attracts Participants from 5 Countries and 24 States
4/5/2012
-
Medgenics, Inc. Announces Results of 2012 Annual Meeting of Stockholders
4/5/2012
-
Omni Bio Pharmaceutical to Hold Investor Conference Call on April 17
4/5/2012
-
Nile Therapeutics, Inc. Completes $1.34 Million Registered Direct Offering
4/5/2012
-
Summit Corporation Release: Posting of Shareholder Circular
4/5/2012